Ahmad Shoaib1, Harriette G C Van Spall2,3,4, Jianhua Wu5,6, John G F Cleland7, Theresa A McDonagh8, Muhammad Rashid1, Mohamed O Mohamed1, Fozia Z Ahmed9, John Deanfield10, Mark de Belder11, Chris P Gale5,6,12, Mamas A Mamas1. 1. Keele Cardiovascular Research Group, Centre for Prognosis Research, Institute for Primary Care and Health Sciences, Keele University, United Kingdom (UK). 2. Department of Medicine, Department of Health Research Methods, Evidence, and Impact, McMaster University, Hamilton, Canada. 3. Population Health Research Institute, Hamilton, Canada. 4. ICES, McMaster University, Hamilton, Canada. 5. Leeds Institute for Data Analytics, University of Leeds, Leeds, UK. 6. Leeds Institute for Cardiovascular and Metabolic Medicine, University of Leeds, Leeds, UK. 7. Robertson Centre for Biostatistics, University of Glasgow, UK. 8. School of Cardiovascular Medicine, Kings College, London, UK. 9. Department of Cardiology, Manchester University Hospitals NHS trust, Manchester, UK. 10. Institute of Cardiovascular Sciences, University College London, London, UK. 11. National Institute for Cardiovascular Outcomes Research, Barts Health NHS Trust, London, UK. 12. Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, UK.
Abstract
OBJECTIVE: We hypothesised that a decline in admissions with heart failure during COVID-19 pandemic would lead to a reciprocal rise in mortality for patients with heart failure in the community. METHODS: We used national heart failure audit data to identify 36,974 adults who had a hospital admission with a primary diagnosis of heart failure between February and May in either 2018, 2019 or 2020. RESULTS: Hospital admissions for heart failure in 2018/19 averaged 160/day but were much lower in 2020, reaching a nadir of 64/day on 27th March-2020 (incidence rate ratio:0.40, 95% CI:0.38-0.42). The proportion discharged on guideline-recommended pharmacotherapies was similar in 2018/19 compared to the same period in 2020. Between 1st February-2020 and 31st May-2020, there was a 29% decrease in hospital deaths related to heart failure (IRR:0.71,95% CI:0.67-0.75; estimated decline of 448 deaths), a 31% increase in heart failure deaths at home (IRR:1.31,95% CI:1.24-1.39; estimated excess 539) and a 28% increase in heart failure deaths in care homes and hospices (IRR:1.28,95% CI:1.18-1.40; estimated excess 189). All-cause, in-patient death was similar in the COVID-19 and pre-COVID-19 periods (OR:1.02,95% CI: 0.94-1.10). After hospital discharge, 30-day mortality was higher in 2020 compared to 2018/19 (OR:1.57, 95% CI:1.38-1.78). CONCLUSION: Compared with the rolling daily average in 2018/19, there was a substantial decline in admissions for heart failure but an increase in deaths from heart failure in the community. Despite similar rates of prescription of guideline-recommended therapy, mortality 30-days from discharge was higher during the COVID-19 pandemic period.
OBJECTIVE: We hypothesised that a decline in admissions with heart failure during COVID-19 pandemic would lead to a reciprocal rise in mortality for patients with heart failure in the community. METHODS: We used national heart failure audit data to identify 36,974 adults who had a hospital admission with a primary diagnosis of heart failure between February and May in either 2018, 2019 or 2020. RESULTS: Hospital admissions for heart failure in 2018/19 averaged 160/day but were much lower in 2020, reaching a nadir of 64/day on 27th March-2020 (incidence rate ratio:0.40, 95% CI:0.38-0.42). The proportion discharged on guideline-recommended pharmacotherapies was similar in 2018/19 compared to the same period in 2020. Between 1st February-2020 and 31st May-2020, there was a 29% decrease in hospital deaths related to heart failure (IRR:0.71,95% CI:0.67-0.75; estimated decline of 448 deaths), a 31% increase in heart failure deaths at home (IRR:1.31,95% CI:1.24-1.39; estimated excess 539) and a 28% increase in heart failure deaths in care homes and hospices (IRR:1.28,95% CI:1.18-1.40; estimated excess 189). All-cause, in-patient death was similar in the COVID-19 and pre-COVID-19 periods (OR:1.02,95% CI: 0.94-1.10). After hospital discharge, 30-day mortality was higher in 2020 compared to 2018/19 (OR:1.57, 95% CI:1.38-1.78). CONCLUSION: Compared with the rolling daily average in 2018/19, there was a substantial decline in admissions for heart failure but an increase in deaths from heart failure in the community. Despite similar rates of prescription of guideline-recommended therapy, mortality 30-days from discharge was higher during the COVID-19 pandemic period.
Authors: Jan M Stratil; Renke L Biallas; Jacob Burns; Laura Arnold; Karin Geffert; Angela M Kunzler; Ina Monsef; Julia Stadelmaier; Katharina Wabnitz; Tim Litwin; Clemens Kreutz; Anna Helen Boger; Saskia Lindner; Ben Verboom; Stephan Voss; Ani Movsisyan Journal: Cochrane Database Syst Rev Date: 2021-09-15
Authors: Thomas A Kite; Amerjeet S Banning; Andrew Ladwiniec; Chris P Gale; John P Greenwood; Miles Dalby; Rachel Hobson; Shaun Barber; Emma Parker; Colin Berry; Marcus D Flather; Nick Curzen; Adrian P Banning; Gerry P McCann; Anthony H Gershlick Journal: BMJ Open Date: 2022-05-03 Impact factor: 3.006
Authors: Zahi Abu Ghosh; Donna R Zwas; Andre Keren; Gabby Elbaz-Greener; Vered Israeli; Offer Amir; Israel Gotsman Journal: J Clin Med Date: 2021-11-27 Impact factor: 4.241
Authors: Giuseppe Rosano; Ewa A Jankowska; Robin Ray; Marco Metra; Magdy Abdelhamid; Stamatis Adamopoulos; Stefan D Anker; Antoni Bayes-Genis; Yury Belenkov; Tuvia B Gal; Michael Böhm; Ovidiu Chioncel; Alain Cohen-Solal; Dimitrios Farmakis; Gerasimos Filippatos; Arantxa González; Finn Gustafsson; Loreena Hill; Tiny Jaarsma; Fadi Jouhra; Mitja Lainscak; Ekaterini Lambrinou; Yury Lopatin; Lars H Lund; Davor Milicic; Brenda Moura; Wilfried Mullens; Massimo F Piepoli; Piotr Ponikowski; Amina Rakisheva; Arsen Ristic; Gianluigi Savarese; Petar Seferovic; Michele Senni; Thomas Thum; Carlo G Tocchetti; Sophie Van Linthout; Maurizio Volterrani; Andrew J S Coats Journal: Eur J Heart Fail Date: 2021-11 Impact factor: 15.534
Authors: Lauren A Moreau; Ivana Holloway; Beth Fylan; Suzanne Hartley; Bonnie Cundill; Alison Fergusson; Sarah Alderson; David Phillip Alldred; Chris Bojke; Liz Breen; Hanif Ismail; Peter Gardner; Ellen Mason; Catherine Powell; Jonathan Silcock; Andrew Taylor; Amanda Farrin; Chris Gale Journal: BMJ Open Date: 2022-04-29 Impact factor: 3.006